Contact Us

Drug Makers Ignore Patient Side Effects with Drugs Like Xarelto

Posted on in Xarelto Claims

Xarelto side effects, drug makers, Chicago product liability attorneyDrug manufacturers have to put drugs through testing before they are approved for use by consumers. But what happens when adverse side effects start appearing in patients using the drug because information given to the Food and Drug Administration (FDA) was incomplete? Eventually the drug may be pulled off the shelf, but patients who used the drug become a statistic to be used for further tests. Patients should not be another defective drug product liability statistic for pharmaceutical companies.

study by the Institute for Safe Medication Practices revealed that drug manufacturers often do not file complete, basic reports about adverse side effects with the FDA. Just over 50 percent of the reports filed did not meet the basic reporting standard, which should contain age, gender, and an event date.

Throughout the years, “blockbuster drugs” have been approved by the FDA, and then later pulled off the shelves, but not before the cost of lives or life-altering side effects were paid. A blockbuster drug is one that:

  • Can be used by almost everyone;
  • Is used every day;
  • Is used indefinitely;
  • Solves an everyday health problem;
  • Has a fun or memorable ad campaign;
  • Gets social buzz; and
  • Is sold to a large number of people quickly.

The last condition of a blockbuster drug is important to pharmaceutical companies, but at the expense of patients taking the drug. Adverse side effects may not be shown until millions of patients are already taking the prescribed drug. This is when reporting adverse side effects to the FDA is critical, but instead is inadequate. The side effects from defective drugs can lead to life-altering side effects or death, such as was the case with Vioxx or Xarelto.

Xarelto (known generically as Rivaroxaban) is a new-generation blood thinner used to reduce the risk of blood clots and strokes.   Xarelto has been linked to an increased risk of uncontrollable bleeding (hemorrhaging). Other blood thinners like Coumadin [warfarin] have an antidote when bleeding occurs.  However, Xarelto was submitted by its manufacturer to the US Food and Drug Administration (FDA) for approval even though there is no known antidote to the drug when it’s most severe side-effect—uncontrolled bleeding—occurs.

Many lives might be saved if drug manufacturers did not view patients as statistics instead of patients. Patients are people, not numbers and should be treated as such. Purposefully concealing adverse side effects of defective drugs at the expense of patients is not ethical and may lead consumers to file product liability cases against the company.

Drug manufacturers should be held accountable for their advertising and concealment if they knew a drug was defective and still sold it. If you or a family member has been affected or died from adverse side effects of a defective drug like Xarelto, contact a Chicago product liability attorney today. Call the law office of Hurley McKenna & Mertz, P.C., at 312-553-4900 for a free consultation.

To Top